Caveolin-1 abolishment attenuates the myogenic response in murine cerebral arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 3, 2007, Pages

  Adebiyi, Adebowale ^a   Zhao, Guiling ^a   Cheranov, Sergey Y ^a   Ahmed, Abu ^a   Jaggar, Jonathan H ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Arterial wall calcium; Calcium activated potassium channels; Membrane depolarization

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CAVEOLIN 1; DILTIAZEM; IBERIOTOXIN; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY MUSCLE; ARTICLE; ATTENUATION; BLOOD PRESSURE; BRAIN ARTERY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CAVEOLA; CELL FUNCTION; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; CALCIUM; CAVEOLIN 1; CEREBRAL ARTERIES; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; VASOCONSTRICTION;

EID: 33847729462     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00584.2006     Document Type: Article

References (50)

1. Ambudkar IS, Brazer SC, Liu X, Lockwich T, Singh B. Plasma membrane localization of TRPC channels: role of caveolar lipid rafts. Novartis Found Symp 258: 63-70, 2004.
2. Anderson RG. Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 90: 10909-10913, 1993.
3. Bayliss WM. On the local reactions of the arterial wall to changes in internal pressure. J Physiol 28: 220-231, 1902.
4. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 256: 532-535, 1992.
5. Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, Aldrich RW. Vasoregulation by the β1 subunit of the calcium-activated potassium channel. Nature 407: 870-876, 2000.
6. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6: 1362-1367, 2000.
7. 2+ spark coupling in murine arterial smooth muscle cells. Am J Physiol Heart Circ Physiol 290: H2309-H2319, 2006.
8. Cohen AW, Park DS, Woodman SE, Williams TM, Chandra M, Shirani J, Pereira de SA, Kitsis RN, Russell RG, Weiss LM, Tang B, Jelicks LA, Factor SM, Shtutin V, Tanowitz HB, Lisanti MP. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 284: C457-C474, 2003.
9. 2+ handling. Am J Physiol Lung Cell Mol Physiol 279: L1226-L1235, 2000.
10. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79: 387-423, 1999.
11. Davis MJ, Wu X, Nurkiewicz TR, Kawasaki J, Davis GE, Hill MA, Meininger GA. Integrins and mechanotransduction of the vascular myogenic response. Am J Physiol Heart Circ Physiol 280: H1427-H1433, 2001.
12. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452, 2001.
13. Dreja K, Voldstedlund M, Vinten J, Tranum-Jensen J, Hellstrand P, Sward K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler Thromb Vasc Biol 22: 1267-1272, 2002.
14. + channel proteins: components of a vascular mechanosensor. Hypertension 44: 643-648, 2004.
15. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78: 53-97, 1998.
16. Fujita T, Toya Y, Iwatsubo K, Onda T, Kimura K, Umemura S, Ishikawa Y. Accumulation of molecules involved in alpha1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy. Cardiovasc Res 51: 709-716, 2001.
17. 2+ sensitivity as a key mechanism of PKC-induced constriction in pressurized cerebral arteries. Am J Physiol Heart Circ Physiol 277: H1178-H1188, 1999.
18. Gokina NI, Park KM, Elroy-Yaggy K, Osol G. Effects of Rho kinase inhibition on cerebral artery myogenic tone and reactivity. J Appl Physiol 98: 1940-1948, 2005.
19. Goto Y, Yoshikane H, Honda M, Morioka S, Yamori Y, Moriyama K. Three-dimensional observation on sarcoplasmic reticulum and caveolae in myocardium of spontaneously hypertensive rats. J Submicrosc Cytol Pathol 22: 535-542, 1990.
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
21. Hnasko R, Lisanti MP. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol Interv 3: 445-464, 2003.
22. 2+ signaling in cerebral artery smooth muscle cells. Am J Physiol Cell Physiol 281: C439-C448, 2001.
23. + channels. Circ Res 91: 610-617, 2002.
24. Jaggar JH, Porter VA, Lederer WJ, Nelson MT. Calcium sparks in smooth muscle. Am J Physiol Cell Physiol 278: C235-C256, 2000.
25. 2+ sparks in intact cerebral arteries. Am J Physiol Cell Physiol 274: C1755-C1761, 1998.
26. Jang IH, Kim JH, Lee BD, Bae SS, Park MH, Suh PG, Ryu SH. Localization of phospholipase C-gamma1 signaling in caveolae: importance in EGF-induced phosphoinositide hydrolysis but not in tyrosine phosphorylation. FEBS Lett 491: 4-8, 2001.
27. Je HD, Gallant C, Leavis PC, Morgan KG. Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol 286: H91-H98, 2004.
28. + channels in rabbit myogenic cerebral arteries. Am J Physiol Heart Circ Physiol 269: H348-H355, 1995.
29. 2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol 508: 199-209, 1998.
30. Minshall RD, Sessa WC, Stan RV, Anderson RG, Malik AB. Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 285: L1179-L1183, 2003.
31. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ. Relaxation of arterial smooth muscle by calcium sparks. Science 270: 633-637, 1995.
32. Nelson MT, Conway MA, Knot HJ, Brayden JE. Chloride channel blockers inhibit myogenic tone in rat cerebral arteries. J Physiol 502: 259-264, 1997.
33. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
34. Osol G, Laher I, Kelley M. Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am J Physiol Heart Circ Physiol 265: H415-H420, 1993.
35. Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol 160: 2207-2217, 2002.
36. 2+ entry in cannulated and pressurized skeletal muscle arterioles. Br J Pharmacol 134: 247-256, 2001.
37. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di VD, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 38121-38138, 2001.
38. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467, 2002.
39. Rosenblum WI, Nelson GH, Povlishock JT. Laser-induced endothelial damage inhibits endothelium-dependent relaxation in the cerebral microcirculation of the mouse. Circ Res 60: 169-176, 1987.
40. Schulz R, Triggle CR. Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol Sci 15: 255-259, 1994.
41. 2+ oscillations and tone. Cardiovasc Res 69: 825-835, 2006.
42. Suginta W, Karoulias N, Aitken A, Ashley RH. Chloride intracellular channel protein CLIC4 (p64H1) binds directly to brain dynamin I in a complex containing actin, tubulin and 14-3-3 isoforms. Biochem J 359: 55-64, 2001.
43. 2+ sensitization of arterial muscle. Am J Physiol Cell Physiol 285: C1377-C1385, 2003.
44. Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol 144: 1285-1294, 1999.
45. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 90: 248-250, 2002.
46. Woodman SE, Cheung MW, Tarr M, North AC, Schubert W, Lagaud G, Marks CB, Russell RG, Hassan GS, Factor SM, Christ GJ, Lisanti MP. Urogenital alterations in aged male caveolin-1 knockout mice. J Urol 171: 950-957, 2004.
47. Yu J, Bergaya S, Murata T, Alp IF, Bauer MP, Lin MI, Drab M, Kurzchalia TV, Stan RV, Sessa WC. Direct evidence for the role of caveolin-1 and caveolae in mechanotransduction and remodeling of blood vessels. J Clin Invest 116: 1284-1291, 2006.
48. +-induced constriction: role for SOCs in small arteries. Am J Physiol Heart Circ Physiol 283: H2692-H2705, 2002.
49. Zhao YY, Liu Y, Stan RV, Fan L, Gu Y, Dalton N, Chu PH, Peterson K, Ross J Jr, Chien KR. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci USA 99: 11375-11380, 2002.
50. Zulli A, Buxton BF, Black MJ, Ming Z, Cameron A, Hare DL. The immunoquantification of caveolin-1 and eNOS in human and rabbit diseased blood vessels. J Histochem Cytochem 54: 151-159, 2006.